Trial intelligence / Profile preview

Phase II study of vorinostat + bortezomib + dexamethasone in relapsed multiple myeloma

2011-005361-20Phase 2Completed

Sponsor

University of Leeds

Start

Dec 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules

Countries

1